Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check4 days agoChange DetectedThe page shows minor layout and formatting updates to the study record without altering core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedAdditions introduce an operational status notice and new version v3.2.0; deletions remove the prior v3.1.0 tag. The most significant change is the updated operational status messaging and the version bump.SummaryDifference4%

- Check40 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to acute myeloid leukemia and various chemical compounds. Notably, previous mentions of acute graft versus host disease and other leukemia types have been removed.SummaryDifference4%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.